
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
ZEN Graphene Solutions Ltd (ZTEK)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/12/2025: ZTEK (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $
1 Year Target Price $
1 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -31.13% | Avg. Invested days 25 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 120.99M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.65 | 52 Weeks Range 0.50 - 1.84 | Updated Date 06/29/2025 |
52 Weeks Range 0.50 - 1.84 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.07 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -250.85% |
Management Effectiveness
Return on Assets (TTM) -28.33% | Return on Equity (TTM) -57.5% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 118903713 | Price to Sales(TTM) 138.67 |
Enterprise Value 118903713 | Price to Sales(TTM) 138.67 | ||
Enterprise Value to Revenue 185.95 | Enterprise Value to EBITDA -10.41 | Shares Outstanding 104311000 | Shares Floating 89505034 |
Shares Outstanding 104311000 | Shares Floating 89505034 | ||
Percent Insiders 6.06 | Percent Institutions 1.54 |
Analyst Ratings
Rating 5 | Target Price - | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
ZEN Graphene Solutions Ltd
Company Overview
History and Background
ZEN Graphene Solutions Ltd. was founded in 2013. The company focuses on the research, development, and commercialization of graphene-based technologies. It has evolved from exploring graphite deposits to developing graphene-enhanced solutions for various industries.
Core Business Areas
- Graphene Products: Production and sale of graphene-based materials, including graphene quantum dots, graphene oxide, and reduced graphene oxide.
- ZENGuard Antibacterial Coating: Development and commercialization of the ZENGuard antibacterial coating using graphene, applicable to PPE and other surfaces.
- Thermal Management: Development of graphene-enhanced thermal interface materials for electronic devices.
Leadership and Structure
Dr. Francis Dubu00e9 is the Chief Executive Officer. The company has a board of directors and a management team overseeing operations, R&D, and commercialization efforts.
Top Products and Market Share
Key Offerings
- ZENGuard Antibacterial Coating: ZENGuard is an antibacterial coating using graphene for PPE and other materials. While specific market share data is not readily available, it competes with other antimicrobial coatings from companies like Bio-Gate AG and Sciessent. Revenue from this product varies but is a key focus of the company. It is also sold as StrainSecure in partnership with EkoMed Global Inc. It is estimated the global Antiviral coating market is 2 Billion USD with annual growth.
- Graphene Quantum Dots: Graphene quantum dots (GQDs) are used in various applications including sensors and bioimaging. Competitors include Quantum Materials Corp. and Graphene Square. The market is growing with increased demand for advanced materials. Market share data is not disclosed by the company.
Market Dynamics
Industry Overview
The graphene market is expanding, driven by its unique properties and applications across sectors like electronics, healthcare, and materials science.
Positioning
ZEN Graphene Solutions focuses on specific high-value applications of graphene, particularly in antibacterial coatings and thermal management, aiming for a niche market presence with superior products. They are positioned as a materials solution provider, not just a graphene supplier.
Total Addressable Market (TAM)
The total addressable market for graphene is projected to reach billions of dollars. ZEN Graphene Solutions is positioned to capture a portion of this market through its specialized product offerings, focusing on antibacterial solutions and thermal interface materials. The total graphene market is expected to reach $1.4 billion by 2027 and the anti-microbial coating market has been estimated at around $2 Billion.
Upturn SWOT Analysis
Strengths
- Proprietary graphene production process
- Focus on high-value applications
- Partnerships for commercialization
- Strong R&D capabilities
Weaknesses
- Limited revenue generation
- Reliance on strategic partnerships
- Competition from larger materials companies
- Small market capitalization
Opportunities
- Growing demand for graphene-based solutions
- Expansion into new applications
- Strategic acquisitions
- Government funding for graphene research
Threats
- Fluctuations in raw material prices
- Technological disruptions
- Regulatory hurdles
- Economic downturns
Competitors and Market Share
Key Competitors
- PRFX
- NANXF
- USG
Competitive Landscape
ZEN Graphene Solutions competes with larger materials companies and specialized graphene producers. Their advantage lies in specific application areas and proprietary technology but is at a disadvantage due to their lower market capitalization.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by advancements in graphene technology and strategic partnerships.
Future Projections: Future growth depends on successful commercialization of ZENGuard and expansion into new markets. Analyst estimates can be tracked for detailed forecasts.
Recent Initiatives: Recent initiatives include expanding production capacity for ZENGuard and securing additional partnerships.
Summary
ZEN Graphene Solutions is a company focused on graphene applications with a promising antibacterial coating product. While it has strengths in R&D and proprietary technology, it faces challenges from larger competitors and relies on partnerships for commercialization. Successful expansion of ZENGuard and other product lines will be crucial for its future growth. Cashflow and consistent revenue generation are key considerations.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- Financial reports
- Industry reports
- Analyst reports
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market conditions and company performance can change rapidly. Stock symbols might trade on multiple exchanges; the ones selected may not be the primary listing.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About ZEN Graphene Solutions Ltd
Exchange NASDAQ | Headquaters Guelph, ON, Canada | ||
IPO Launch date 2012-04-02 | CEO & Director Mr. Gregory Fenton C.F.A. | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 24 | Website https://www.zentek.com |
Full time employees 24 | Website https://www.zentek.com |
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing aptamers and rapid detection; and graphene oxide synthesis and graphene synthesis. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.